Praxis Precision Medicines
Watchlist
Praxis Precision Medicines: 11 Buy Recommendations with Price Targets Between $232 and $441 Following Surprising Study Data!

Reading Time: 4 minutes
Praxis Precision Medicines (PRAX) is a clinical-stage biopharmaceutical company that translates insights from genetic epilepsies into the development of therapies for CNS disorders (central nervous system disorders) characterized by an imbalance between neuronal excitation and inhibition. Praxis utilizes genetic insights for the discovery and development of therapies for rare and more common neurological disorders through its proprietary small molecule platform, Cerebrum, and its antisense oligonucleotide (ASO) platform, Solidus, leveraging understanding...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.